Media Summary: Recent data from 1SURMOUNT-1 clinical trial showed that Can Weight-Loss Medications Like Wegovy and Zepbound Help Fight JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy ...

60 Second Journal Club Tirzepatide For Heart Failure And Obesity - Detailed Analysis & Overview

Recent data from 1SURMOUNT-1 clinical trial showed that Can Weight-Loss Medications Like Wegovy and Zepbound Help Fight JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy ... The GLP-1 receptor agonist semaglutide can reduce adverse Take the free GLP-1 qualification quiz at — TelehealthFX offers semaglutide, the ONLY A generic version of semaglutide, more commonly known by the brand name Ozempic, is now available in Canada as patent ...

THT Conference 2025 - Outcomes assessing the effect of

Photo Gallery

Tirzepatide for Heart Failure in Patients with Obesity | NEJM
NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
30% Weight Loss?! Retatrutide CRUSHES Zepbound
Journal Club - Tirzepatide may lead weight loss of up to 23 percent in obese people
Wegovy, Zepbound, and Heart Failure: Can These Medications Help? | Dr. Dan | Obesity Expert
Semaglutide in Heart Failure with Obesity | NEJM
Tirzepatide and Cardiac Structure in Obesity-related HFpEF: SUMMIT CMR Substudy | JACC | AHA 2024
Tirzepatide vs Dulaglutide for Cardiorenal Outcomes (SURPASS-CVOT) | JAMA | Med Journal Club
Semaglutide and Cardiovascular Outcomes in Obesity | NEJM
Cardiac & Renal Outcomes with Efpeglenatide in Diabetes (AMPLITUDE-O) | NEJM | Med Journal Club
GLP-1 and Your Heart: How Semaglutide Reduces Heart Attacks & Strokes by 20% (SELECT Trial 2026)
Tirzepatide versus Semaglutide in Type 2 Diabetes (SURPASS-2) | NEJM | Med Journal Club
Sponsored
Sponsored
View Detailed Profile
Tirzepatide for Heart Failure in Patients with Obesity | NEJM

Tirzepatide for Heart Failure in Patients with Obesity | NEJM

Tirzepatide

NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

Eric Rubin is the Editor-in-Chief of the

Sponsored
30% Weight Loss?! Retatrutide CRUSHES Zepbound

30% Weight Loss?! Retatrutide CRUSHES Zepbound

Retatrutide may be the most powerful

Journal Club - Tirzepatide may lead weight loss of up to 23 percent in obese people

Journal Club - Tirzepatide may lead weight loss of up to 23 percent in obese people

Recent data from 1SURMOUNT-1 clinical trial showed that

Wegovy, Zepbound, and Heart Failure: Can These Medications Help? | Dr. Dan | Obesity Expert

Wegovy, Zepbound, and Heart Failure: Can These Medications Help? | Dr. Dan | Obesity Expert

Can Weight-Loss Medications Like Wegovy and Zepbound Help Fight

Sponsored
Semaglutide in Heart Failure with Obesity | NEJM

Semaglutide in Heart Failure with Obesity | NEJM

Many patients with

Tirzepatide and Cardiac Structure in Obesity-related HFpEF: SUMMIT CMR Substudy | JACC | AHA 2024

Tirzepatide and Cardiac Structure in Obesity-related HFpEF: SUMMIT CMR Substudy | JACC | AHA 2024

JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy ...

Tirzepatide vs Dulaglutide for Cardiorenal Outcomes (SURPASS-CVOT) | JAMA | Med Journal Club

Tirzepatide vs Dulaglutide for Cardiorenal Outcomes (SURPASS-CVOT) | JAMA | Med Journal Club

In this

Semaglutide and Cardiovascular Outcomes in Obesity | NEJM

Semaglutide and Cardiovascular Outcomes in Obesity | NEJM

The GLP-1 receptor agonist semaglutide can reduce adverse

Cardiac & Renal Outcomes with Efpeglenatide in Diabetes (AMPLITUDE-O) | NEJM | Med Journal Club

Cardiac & Renal Outcomes with Efpeglenatide in Diabetes (AMPLITUDE-O) | NEJM | Med Journal Club

Cardiovascular

GLP-1 and Your Heart: How Semaglutide Reduces Heart Attacks & Strokes by 20% (SELECT Trial 2026)

GLP-1 and Your Heart: How Semaglutide Reduces Heart Attacks & Strokes by 20% (SELECT Trial 2026)

Take the free GLP-1 qualification quiz at https://go.telehealthfx.com/start — TelehealthFX offers semaglutide, the ONLY

Tirzepatide versus Semaglutide in Type 2 Diabetes (SURPASS-2) | NEJM | Med Journal Club

Tirzepatide versus Semaglutide in Type 2 Diabetes (SURPASS-2) | NEJM | Med Journal Club

Tirzepatide

4 keys facts about generic GLP-1s for weight loss

4 keys facts about generic GLP-1s for weight loss

A generic version of semaglutide, more commonly known by the brand name Ozempic, is now available in Canada as patent ...

THT 2025: SUMMIT: Impact of Obesity Severity on Tirzepatide in HFpEF

THT 2025: SUMMIT: Impact of Obesity Severity on Tirzepatide in HFpEF

THT Conference 2025 - Outcomes assessing the effect of